Background Meeting increased regulatory requirements for clinical evaluation of medical
devices marketed in Europe in accordance with the Medical Device Regulation (EU …

Pulmonary stenosis (PS) is mainly a congenital defect that accounts for 7–12% of congenital
heart diseases (CHD). It can be isolated or, more frequently, associated with other …

Background There are limited published data focused on outcomes of transcatheter
pulmonary valve replacement (TPVR) with either a Sapien XT or Sapien 3 (S3) valve …

Background Endocarditis has emerged as one of the most impactful adverse events after
transcatheter pulmonary valve replacement (TPVR), but there is limited information about …

Right ventricular outflow tract (RVOT) dysfunction is common following surgical repair of
tetralogy of Fallot and other forms of complex congenital heart disease. This results in …

Transcatheter pulmonary valve replacement (TPVR) is a minimally invasive procedure for
treatment of right ventricular outflow tract (RVOT) dysfunction in surgically repaired …

Abstract Background and Aims Transcatheter pulmonary valve implantation (TPVI) is
indicated to treat right-ventricular outflow tract (RVOT) dysfunction related to congenital heart …

Background Infective endocarditis (IE) after pulmonary valve replacements in congenital
heart disease is a significant concern. This study aimed to identify specific long‐term risk …

Background Transcatheter pulmonary valve implantation (TPVI) is effective for treating right
ventricle outflow tract (RVOT) dysfunction. Factors associated with long-term valve durability …

This consensus document for the performance of cardiovascular computed tomography
(CCT) to guide intervention in the right ventricular outflow tract (RVOT) in patients with …